Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?


Of novel risk factors for cardiovascular disease currently under investigation, high-sensitivity C-reactive protein (hsCRP) is the most promising. To date, more than 20 prospective epidemiologic studies have demonstrated that hsCRP independently predicts vascular risk, 6 cohort studies have confirmed that hsCRP evaluation adds prognostic information beyond… (More)


7 Figures and Tables

Slides referencing similar topics